Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLRN | NAUT | CABA | ||
| Company | Acelyrin Inc | Nautilus Biotechnology Inc | Cabaletta Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.24 | 1.8700 | 2.40 | ||
| High | 2.36 | 2.0400 | 2.45 | ||
| Low | 2.20 | 1.8600 | 2.33 | ||
| Latest | 2.27 | 1.9000 | 2.39 | ||
| Change | +0.04 | +0.0500 | +0.03 | ||
| % Change | +1.79% | +2.70% | +1.27% | ||
| Volume | 4,076,500 | 549,000 | 1,816,600 | ||
| 20-Day Average Volume | 1,091,300 | 349,780 | 2,324,070 | ||
| Previous Close | 2.23 | 1.8500 | 2.36 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.33 | 2.0817 | 2.38 | ||
| 20-Day Raw Stochastic | 45.16% | 13.51% | 55.07% | ||
| 20-Day Relative Strength | 47.29 | 53.42 | 49.25 | ||
| Weighted Alpha | -28.45 | +43.11 | -35.20 | ||
| Today's Opinion | 88% Sell | 88% Buy | 56% Buy | ||
| Previous Opinion | 88% Sell | 88% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Sell | 88% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.61% since 05/13/25 | -6.40% since 12/08/25 | -3.63% since 12/08/25 | ||
| Low | 1.95 on 05/15/25 | 1.8450 on 12/12/25 | 2.33 on 12/15/25 | ||
| High | 2.36 on 05/20/25 | 2.1393 on 12/09/25 | 2.55 on 12/09/25 | ||
| 1-Month | |||||
| %Chg | +3.18% since 04/17/25 | +5.56% since 11/14/25 | +3.46% since 11/14/25 | ||
| Low | 1.95 on 05/15/25 | 1.8000 on 11/17/25 | 2.01 on 11/21/25 | ||
| High | 2.65 on 05/01/25 | 2.5400 on 11/20/25 | 2.70 on 12/05/25 | ||
| 3-Month | |||||
| %Chg | +4.61% since 02/20/25 | +145.35% since 09/15/25 | +25.13% since 09/15/25 | ||
| Low | 1.95 on 05/15/25 | 0.6810 on 09/19/25 | 1.90 on 09/16/25 | ||
| High | 2.94 on 04/02/25 | 2.5400 on 11/20/25 | 3.67 on 10/31/25 | ||
| 6-Month | |||||
| %Chg | -48.76% since 11/20/24 | +171.04% since 06/13/25 | +20.10% since 06/13/25 | ||
| Low | 1.85 on 02/11/25 | 0.6200 on 09/04/25 | 1.26 on 08/12/25 | ||
| High | 5.03 on 11/25/24 | 2.5400 on 11/20/25 | 3.67 on 10/31/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 229,166 | 233,664 | 227,185 | ||
| Shares Outstanding, K | 100,954 | 126,305 | 96,265 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -248,230,000 | -70,780,000 | -115,860,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -55,260,000 | -13,570,000 | -44,870,000 | ||
| 60-Month Beta | 1.07 | 1.48 | 3.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 05/14/25 | -0.11 on 10/27/25 | -0.44 on 11/10/25 | ||
| Latest Earnings Date | 08/12/25 | 02/25/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||